US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Evommune

7.21

-1.0500-12.71%

Post-market: 7.20-0.0100-0.14%19:40 EDT

Volume:1.53M

Turnover:11.08M

Market Cap:261.67M

PE:-2.76

High:8.30

Open:8.25

Low:6.99

Close:8.26

52wk High:33.20

52wk Low:6.99

Shares:36.29M

Float Shares:19.98M

Volume Ratio:2.05

T/O Rate:7.63%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.6090

EPS(LYR):-11.2228

ROE:-52.11%

ROA:-31.99%

PB:0.94

PE(LYR):-0.64

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

US Stocks on the MOVE-Cardinal Health, nVent, Acuity

Evommune Gains After Eczema Drug Meets Mid-Stage Trial Goal

Evommune presents Phase 2a PoC data on EVO301 at EADV Congress

Evommune Says Phase 2a Trial Shows Evo301 Cuts EASI 55% at Week 12 in Atopic Dermatitis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/EVMN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EVMN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVMN\",,,,,undefined,":{"symbol":"EVMN","market":"US","secType":"STK","nameCN":"Evommune","latestPrice":7.21,"timestamp":1790884800000,"preClose":8.26,"halted":0,"volume":1525172,"hourTrading":{"tag":"盘后","latestPrice":7.2,"preClose":7.21,"latestTime":"19:40 EDT","volume":29965,"amount":215232.8508,"timestamp":1790898004365,"change":-0.01,"changeRate":-0.001387,"amplitude":0.059639},"delay":0,"changeRate":-0.1271186440677966,"floatShares":19982000,"shares":36292113,"eps":-2.609,"marketStatus":"Closed","change":-1.05,"latestTime":"10-01 16:00:00 EDT","open":8.25,"high":8.3,"low":6.99,"amount":11075769.323146,"amplitude":0.158596,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.609,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790928000000},"marketStatusCode":5,"adr":0,"listingDate":1762405200000,"exchange":"NYSE","adjPreClose":8.26,"preHourTrading":{"tag":"盘前","latestPrice":8.6317,"preClose":8.26,"latestTime":"09:26 EDT","volume":3883,"amount":32990.748482999996,"timestamp":1790861205542,"change":0.3717,"changeRate":0.045,"amplitude":0.065206},"postHourTrading":{"tag":"盘后","latestPrice":7.2,"preClose":7.21,"latestTime":"19:40 EDT","volume":29965,"amount":215232.8508,"timestamp":1790898004365,"change":-0.01,"changeRate":-0.001387,"amplitude":0.059639},"volumeRatio":2.046164,"impliedVol":0.8852,"impliedVolPercentile":0.3125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVMN\",,,,,undefined,":{"symbol":"EVMN","floatShares":19982000,"roa":"-31.99%","roe":"-52.11%","lyrEps":-11.222761,"volumeRatio":2.046164,"shares":36292113,"dividePrice":0,"high":8.3,"amplitude":0.158596,"preClose":8.26,"low":6.99,"week52Low":6.99,"pbRate":"0.94","psRate":"26.17","week52High":33.2,"institutionHeld":0,"latestPrice":7.21,"eps":-2.609,"divideRate":0,"volume":1525172,"delay":0,"ttmEps":-2.609,"open":8.25,"prevYearClose":17.12,"prevWeekClose":8.49,"prevMonthClose":8.26,"prevQuarterClose":8.26,"fiveDayClose":8.8,"twentyDayClose":12.48,"sixtyDayClose":13.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EVMN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"EVMN","fiscalQuarterEnding":"2026/06","expectedEps":-0.68,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.89},{"market":"US","date":"2026-05-07","symbol":"EVMN","fiscalQuarterEnding":"2026/03","expectedEps":-0.83,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2026-03-05","symbol":"EVMN","fiscalQuarterEnding":"2025/12","expectedEps":-0.82,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-1.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EVMN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EVMN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5833,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1787803200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EVMN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EVMN","date":"2026-09-30","current":-2.763511,"percent":1,"low":-16.229076,"twenty":-12.312511,"median":-9.499947,"eighty":-5.563748,"high":-3.201073,"avg":-9.308262,"sd":3.211044,"marketCap":303039143},"quantilePoints":[{"date":"2025-11-07","current":-9.395174,"twenty":-7.823584,"median":-7.430686,"eighty":-7.430686,"marketCap":608469038},{"date":"2025-11-14","current":-8.461694,"twenty":-9.04686,"median":-8.505813,"eighty":-7.430686,"marketCap":548013143},{"date":"2025-11-21","current":-8.689259,"twenty":-9.04686,"median":-8.689259,"eighty":-7.430686,"marketCap":562751147},{"date":"2025-11-28","current":-9.618094,"twenty":-9.051504,"median":-8.707835,"eighty":-8.049291,"marketCap":622906267},{"date":"2025-12-05","current":-10.184684,"twenty":-9.618094,"median":-8.986487,"eighty":-8.483986,"marketCap":659600890},{"date":"2025-12-12","current":-9.657505,"twenty":-9.633858,"median":-9.000419,"eighty":-8.483986,"marketCap":592227156},{"date":"2025-12-19","current":-7.716136,"twenty":-9.618094,"median":-8.986487,"eighty":-8.244704,"marketCap":473176635},{"date":"2025-12-26","current":-9.042428,"twenty":-9.528926,"median":-9.016673,"eighty":-8.355807,"marketCap":554508795},{"date":"2026-01-02","current":-8.800817,"twenty":-9.392482,"median":-9.003431,"eighty":-8.469125,"marketCap":539692472},{"date":"2026-01-09","current":-9.37143,"twenty":-9.380689,"median":-8.972554,"eighty":-8.293747,"marketCap":574684215},{"date":"2026-01-16","current":-10.075701,"twenty":-9.649623,"median":-9.019686,"eighty":-8.354639,"marketCap":617872222},{"date":"2026-01-23","current":-9.710714,"twenty":-9.690151,"median":-9.037572,"eighty":-8.461694,"marketCap":595490116},{"date":"2026-01-30","current":-11.129537,"twenty":-9.775997,"median":-9.042428,"eighty":-8.498847,"marketCap":682496613},{"date":"2026-02-06","current":-8.564346,"twenty":-9.775997,"median":-9.064213,"eighty":-8.549933,"marketCap":525191389},{"date":"2026-02-13","current":-14.332171,"twenty":-9.885497,"median":-9.065437,"eighty":-8.563866,"marketCap":878891712},{"date":"2026-02-20","current":-14.769127,"twenty":-10.094711,"median":-9.253195,"eighty":-8.56425,"marketCap":905687191},{"date":"2026-02-27","current":-13.689588,"twenty":-10.579486,"median":-9.338016,"eighty":-8.621921,"marketCap":839486596},{"date":"2026-03-06","current":-11.484529,"twenty":-11.200535,"median":-9.381712,"eighty":-8.67867,"marketCap":790939493},{"date":"2026-03-13","current":-12.018327,"twenty":-12.245567,"median":-9.479385,"eighty":-8.689259,"marketCap":827702188},{"date":"2026-03-20","current":-12.321662,"twenty":-12.396972,"median":-9.618094,"eighty":-8.70412,"marketCap":848592844},{"date":"2026-03-27","current":-12.379191,"twenty":-12.362455,"median":-9.695292,"eighty":-8.728757,"marketCap":852554865},{"date":"2026-04-02","current":-11.725452,"twenty":-12.336306,"median":-9.710846,"eighty":-8.771001,"marketCap":807531900},{"date":"2026-04-10","current":-14.983685,"twenty":-12.570606,"median":-9.775997,"eighty":-8.798761,"marketCap":1031926357},{"date":"2026-04-17","current":-14.000462,"twenty":-13.015147,"median":-9.975459,"eighty":-8.828576,"marketCap":964211818},{"date":"2026-04-24","current":-13.514081,"twenty":-13.425068,"median":-10.075701,"eighty":-8.877926,"marketCap":930714732},{"date":"2026-05-01","current":-12.44718,"twenty":-13.370677,"median":-10.26642,"eighty":-8.898489,"marketCap":857237253},{"date":"2026-05-08","current":-11.767292,"twenty":-13.351187,"median":-10.76455,"eighty":-8.934568,"marketCap":810413370},{"date":"2026-05-15","current":-10.76944,"twenty":-13.300701,"median":-10.81684,"eighty":-8.966981,"marketCap":818337411},{"date":"2026-05-22","current":-11.162865,"twenty":-13.208546,"median":-10.76944,"eighty":-8.989273,"marketCap":848232660},{"date":"2026-05-29","current":-11.058584,"twenty":-13.135327,"median":-10.864241,"eighty":-9.002829,"marketCap":840308618},{"date":"2026-06-05","current":-9.807205,"twenty":-13.084182,"median":-10.80499,"eighty":-9.017037,"marketCap":745220116},{"date":"2026-06-12","current":-9.807205,"twenty":-13.030837,"median":-10.755219,"eighty":-9.036643,"marketCap":745220116},{"date":"2026-06-18","current":-9.788245,"twenty":-12.946112,"median":-10.53322,"eighty":-9.042258,"marketCap":743779381},{"date":"2026-06-26","current":-11.43779,"twenty":-12.867664,"median":-10.624868,"eighty":-9.042428,"marketCap":869123316},{"date":"2026-07-02","current":-6.07677,"twenty":-12.855112,"median":-10.547048,"eighty":-9.032928,"marketCap":461755529},{"date":"2026-07-10","current":-6.403835,"twenty":-12.813273,"median":-10.376014,"eighty":-8.958621,"marketCap":486608205},{"date":"2026-07-17","current":-5.550622,"twenty":-12.635456,"median":-10.177718,"eighty":-8.800817,"marketCap":421775136},{"date":"2026-07-24","current":-5.36576,"twenty":-12.598847,"median":-10.075701,"eighty":-8.689259,"marketCap":407727971},{"date":"2026-07-31","current":-5.37998,"twenty":-12.561192,"median":-10.06542,"eighty":-8.56425,"marketCap":408808522},{"date":"2026-08-07","current":-5.090694,"twenty":-12.489019,"median":-9.881902,"eighty":-8.43493,"marketCap":481925817},{"date":"2026-08-14","current":-5.393903,"twenty":-12.464961,"median":-9.807205,"eighty":-8.177768,"marketCap":510630029},{"date":"2026-08-21","current":-5.202222,"twenty":-12.450318,"median":-9.782121,"eighty":-7.430686,"marketCap":492483973},{"date":"2026-08-28","current":-5.16772,"twenty":-12.413708,"median":-9.712404,"eighty":-6.987812,"marketCap":489217683},{"date":"2026-09-04","current":-4.600344,"twenty":-12.384421,"median":-9.710846,"eighty":-6.276801,"marketCap":435505356},{"date":"2026-09-11","current":-4.048303,"twenty":-12.366639,"median":-9.695292,"eighty":-6.160195,"marketCap":383244713},{"date":"2026-09-18","current":-3.592102,"twenty":-12.358271,"median":-9.618094,"eighty":-5.832183,"marketCap":340057098},{"date":"2026-09-25","current":-3.373586,"twenty":-12.336306,"median":-9.537021,"eighty":-5.714629,"marketCap":319370594},{"date":"2026-09-30","current":-3.201073,"twenty":-12.312511,"median":-9.499947,"eighty":-5.563748,"marketCap":303039143}],"updateTime":1790906989237},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EVMN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672457769","title":"US Stocks on the MOVE-Cardinal Health, nVent, Acuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2672457769","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672457769?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:00","pubTimestamp":1790877639,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Cardinal Health, nVent, AcuityOct 1 (Reuters)-The S&P 500 fell to a two-week low on Thursday as a global bond selloff, fueled by higher oil prices and inflation concerns, pu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL4N45N1BS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNE","AYI","NESR","TOL","FTEC","ELV","VERI","NU","VICR","KDP","CVS","IETC","SHAZ","ACCV","PRGS","IMNM","VPU","EVMN","MKC","ILDR","IBM","UNH","CEPL","PHM","MU","RDW","ABAT","FCOM","FRVO","LEN","RTH","SNPS","DHI","GOOGL","ACN","GOOP","CAH","BJRI","TMED","GRND","GOOY","RXL","CEG","AAPL","HUM","CTSH","RKLB","FHTX","ORA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752636","title":"Evommune Gains After Eczema Drug Meets Mid-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752636","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752636?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:19","pubTimestamp":1790857151,"startTime":"0","endTime":"0","summary":"BUZZ-Evommune gains after eczema drug meets mid-stage trial goal** Shares of drug developer EvommuneEVMN.Nrise 4.9% to $8.67 premarket** Co says its experimental injectable drug EVO301 met the main goal of a mid-stage trial involving 70 adults with moderate-to-severe atopic dermatitis, commonly known as eczema** Says patients treated with EVO301 had a 55% average reduction in the severity and extent of eczema after 12 weeks, compared with 22% for those given placebo** About 29% of EVO301 patients achieved at least a 75% improvement in eczema severity versus 9% on placebo** Drug was given twice during the trial, at the start and after four weeks; effects continued to improve for eight weeks after the final dose** Treatment-related side effects were reported in 10.4% of EVO301 patients versus 13.6% on placebo; no treatment-related serious or severe side effects were reported** As of last close, EVMN down 51.8% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL4N45N0U5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752683","title":"Evommune presents Phase 2a PoC data on EVO301 at EADV Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752683","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752683?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:15","pubTimestamp":1790856933,"startTime":"0","endTime":"0","summary":"Evommune (EVMN) shared additional data from its Phase 2a proof-of-concept trial of EVO301 in adults with moderate-to-severe atopic dermatitis durin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evommune-presents-phase-2a-poc-data-on-evo301-at-eadv-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evommune-presents-phase-2a-poc-data-on-evo301-at-eadv-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672754276","title":"Evommune Says Phase 2a Trial Shows Evo301 Cuts EASI 55% at Week 12 in Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672754276","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672754276?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:01","pubTimestamp":1790856085,"startTime":"0","endTime":"0","summary":"Evommune says Phase 2a trial shows EVO301 cuts EASI 55% at Week 12 in atopic dermatitisEvommune presented additional Phase 2a proof-of-concept data for EVO301 in moderate-to-severe atopic dermatitis a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL2mzsYz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVMN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":27,"pageCount":1,"totalSize":106,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EVMN\",params:#limit:6,delay:false,,,undefined,":[]}}